Catalyst Wire Dossier Catalyst Wire Dossier

Afimkibart

RO7790121 · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Afimkibart, covering 2026-03-19 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis [Phase 3]

See pricing